Gulf South Angels Invests in Thera B Medical, Paving the Way for Innovative Solutions in Infant Healthcare.

[May 15, 2024] – TheraB Medical, a leading provider of infant healthcare solutions, is thrilled to announce a significant investment from Gulf South Angels, a prominent investment group from the Southern US. This investment will further propel the company's mission to transform the market for treating jaundice in newborns.

Mike Eckert, Chairman of Gulf South Angels, expressed his excitement about the investment, stating, "Gulf South Angels is excited to invest in TheraB Medical. Our diligence process has convinced us that TheraB has the potential to transform the market for treating jaundice in newborns. The unbridled enthusiasm among providers involved in early pilot demonstrations was noteworthy, and we were particularly impressed with the attention to detail and design considerations that have gone into product development. Coupled with the quality of advisors TheraB has surrounded itself with, we look forward to being a part of exciting days ahead. We are always gratified when our members review the diligence and make an affirmative investment decision, but with TheraB, the level of participation was large enough to also trigger additional investment from our Pelican Fund II Sidecar.

Thera B Medical is dedicated to developing innovative solutions that enhance infant healthcare outcomes. This investment from Gulf South Angels will fuel the company's efforts to bring its groundbreaking jaundice treatment technology to market, ultimately improving the lives of infants and families in the US and abroad.

For more information about TheraB Medical please visit  www.therabmedical.com

-------------------------------------------------

About TheraB Medical:
TheraB Medical is a medical technology company focused on improving neonatal care. The company's flagship product, SnugLit, is a portable and wearable phototherapy device designed for the treatment of infant jaundice. TheraB Medical is dedicated to enhancing the health and well-being of infants and children through innovative medical devices.

Contact:
Alexa Jones, CEO, TheraB Medical
Alexa.jones@therabmedical.com

Previous
Previous

TheraB Medical Closes an Oversubscribed Seed Funding Round with Tremendous Support from Investors Across the Country

Next
Next

TheraB Medical Secures Additional Strategic Investment From Foster Lane Investments, LLC